Statins reduce stroke severity, aid recovery

9 March 2009

Researchers from the Mayo Clinic, a specialist cancer research hospital  in the USA, have shown that patients taking statins before a stroke  experienced better outcomes and recovery than those who were not, even  when their cholesterol levels were ideal.

Statins are widely used to improve cardiovascular health and, more  recently, for certain vascular conditions in the brain. One use has been  to lower the level of low-density lipoprotein which can contribute to  arterial blockages.

The findings, reported in the February issue of the Journal of Stroke  and Cerebrovascular Diseases, are from an assessment of 508 patients  who were diagnosed with acute ischemic stroke in the emergency  department during the 22 months from March 2004 to December 2005. Among  them, 207 had their lipid levels measured within 15 days either side of  the stroke and had LDL levels at or under 100mg/dL, which is considered  optimal for healthy individuals.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight